Latest Insider Transactions at Cvs Health Corp (CVS)
This section provides a real-time view of insider transactions for Cvs Health Corp (CVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVS HEALTH Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVS HEALTH Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2014
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
25,575
+35.61%
|
$1,892,550
$74.29 P/Share
|
|
Apr 01
2014
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,028
+11.85%
|
$224,072
$74.29 P/Share
|
|
Apr 01
2014
|
Andrew Sussman EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
4,711
+16.81%
|
$348,614
$74.29 P/Share
|
|
Apr 01
2014
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,843
+16.98%
|
$3,984,382
$74.29 P/Share
|
|
Apr 01
2014
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,778
+16.09%
|
$871,572
$74.29 P/Share
|
|
Apr 01
2014
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,026
-6.04%
|
$149,924
$74.29 P/Share
|
|
Apr 01
2014
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,384
+16.09%
|
$398,416
$74.29 P/Share
|
|
Apr 01
2014
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-11.74%
|
$228,364
$74.29 P/Share
|
|
Mar 31
2014
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,456
-9.36%
|
$259,200
$75.0 P/Share
|
|
Mar 28
2014
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,411
-29.45%
|
$1,140,414
$74.18 P/Share
|